Global Glycomics Market Players Pursue the Strategies of Product Launches, Agreements, Expansions, Acquisitions, and Collaborations

The major players in this market include Agilent Technologies (U.S.), Bruker Corp. (U.S.), Danaher Corp. (U.S.), New England Biolabs (U.S.), Prozyme Inc. (U.S.), Shimadzu Corp. (Japan), Sigma-Aldrich Corp. (U.S.), Takara Bio (Japan), Thermo Fisher Scientific (U.S.), and Waters Corp. (U.S.).
The glycomics market is dominated by a few major players, with the top five players accounting for a majority of the market share. The top four players for glycomics enzymes, kits, and reagents have a combined market share of about 75.2% and for glycomics instruments have a combined market share of about 76.0%.
The global glycomics market is highly evolved, with multiple different product segments. An analysis of market developments between 2011 and 2014 revealed that new product launches was the most important growth strategy employed by market leaders in this period. This strategy was adopted by most players in this market, except New England Biolabs (U.S.) and Takara Bio, Inc. (Japan).
The other important growth strategy adopted by players in this market was expansion. This strategy was implemented to gain immediate technological competency and widen geographic presence. This strategy was adopted by all the players in this market, except Prozyme, Inc. (U.S.), and Waters Corporation (U.S.). Unlike their peers, these companies did not enter into any expansions between 2011 and 2014.
Glycobiology / Glycomics Market

Comments

Popular posts from this blog

Becton, Dickinson and Company (U.S.), B. Braun Melsungen AG (Germany), Baxter International Inc. (U.S.) and ICU Medical, Inc. (U.S.) Dominate the Global IV Equipment Market

Prominent Players and strategies adopted for Gas Chromatography Market

Mckesson Corporation (U.S.), Cerner Corporation (U.S.), and Dolbey Systems, Inc. (U.S.) Dominate The Global Computer-Assisted Coding Market